drugset / Trial / NCT03710434
AZD4635 Relative Bioavailability Study
RandomizedCrossoverOpen-labelBasic science
Summary
To investigate the pharmacokinetics and relative bioavailability of AZD4635 solid oral formulation and compare with the nano-suspension reference formulation with the option to assess food effect, pH effect and absolute bioavailability
Timeline
- Start
- 2018-11-01
- Primary completion
- 2019-04-02
- Completion
- 2019-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lansoprazole | Other / unclassified | 30 mg | — |
| Subject | imaradenant | Small molecule | 50 mg | Oral |
Indications
No indication recorded.